Molecular insights on Eltrombopag: potential mitogen stimulants, angiogenesis, and therapeutic radioprotectant through TPO-R activation

References

• Chang Y, Bluteau D, Debili N, Vainchenker W. From hematopoietic stem cells to platelets. J Thromb Haemost. 2007;5:318–13. doi:10.1111/j.1538-7836.2007.02472.x.
   PubMed Web of Science ®Google Scholar
• Chen W-M, Yu B, Zhang Q, Xu P. Identification of the residues in the extracellular domain of thrombopoietin receptor involved in the binding of thrombopoietin and a nuclear distribution protein (human NUDC). J Biol Chem. 2010;285(34):26697–709. doi:10.1074/jbc.M110.120956.
   PubMed Web of Science ®Google Scholar
• Fox NE, Lim J, Chen R, Geddis AE. F104S c-Mpl responds to a transmembrane domain−binding thrombopoietin receptor agonist: proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agents. Exp Hematol. 2010;38(5):384–91. doi:10.1016/j.exphem.2010.02.007.
   PubMed Web of Science ®Google Scholar
• Besancenot R, Roos-Weil D, Tonetti C, Abdelouahab H, Lacout C, Pasquier F, Willekens C, Rameau P, Lecluse Y, Micol J-B, et al. JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation. Blood J Am Society Hematol. 2014;124(13):2104–15. doi:10.1182/blood-2014-03-559815.
   Google Scholar
• Cines DB, Yasothan U, Kirkpatrick P. Romiplostim. Nat Rev Drug Discov. 2008;7(11):887–9. doi:10.1038/nrd2741.
   PubMed Web of Science ®Google Scholar
• McHutchison JG, Dusheiko G, Shiffman ML, Rodriguez-Torres M, Sigal S, Bourliere M, Berg T, Gordon SC, Campbell FM, Theodore D, et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med. 2007;357(22):2227–36. doi:10.1056/NEJMoa073255.
   PubMed Web of Science ®Google Scholar
• Fox N, Priestley G, Papayannopoulou T, Kaushansky K. Thrombopoietin expands hematopoietic stem cells after transplantation. J Clin Invest. 2002;110(3):389–94. doi:10.1172/JCI0215430.
   PubMed Web of Science ®Google Scholar
• Qian H, Buza-Vidas N, Hyland CD, Jensen CT, Antonchuk J, Månsson R, Thoren LA, Ekblom M, Alexander WS, Jacobsen SEW. et al. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell. 2007;1(6):671–84. doi:10.1016/j.stem.2007.10.008.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao Y, Li X, Han P, Jing F, Kong Z, Zhou H, Qiu J, Li L, Peng J, et al. Thrombopoietin: a potential diagnostic indicator of immune thrombocytopenia in pregnancy. Oncotarget. 2016;7(7):7489. doi:10.18632/oncotarget.7106.
   PubMedGoogle Scholar
• Bussel JB, Soff G, Balduzzi A, Cooper N, Lawrence T, Semple JW. A review of romiplostim mechanism of action and clinical applicability. Drug Des Devel Ther. 2021;15:2243–68. doi:10.2147/DDDT.S299591.
   PubMed Web of Science ®Google Scholar
• Balakrishnan R, Subbarayan R, Shrestha R, Chauhan A, Krishnamoorthy L. Exploring platelet-derived microvesicles in vascular regeneration: unraveling the intricate mechanisms and molecular mediators. Mol Biol Rep. 2024;51(1):393. doi:10.1007/s11033-024-09302-1.
   PubMed Web of Science ®Google Scholar
• Kao Y-R, Chen J, Narayanagari S-R, Todorova TI, Aivalioti MM, Ferreira M, Ramos PM, Pallaud C, Mantzaris I, Shastri A. et al. Thrombopoietin receptor–independent stimulation of hematopoietic stem cells by eltrombopag. Sci Transl Med. 2018;10(458):eaas9563. doi:10.1126/scitranslmed.aas9563.
   PubMed Web of Science ®Google Scholar
• Vlachodimitropoulou E, Chen Y-L, Garbowski M, Koonyosying P, Psaila B, Sola-Visner M, Cooper N, Hider R, Porter J. Eltrombopag: a powerful chelator of cellular or extracellular iron (III) alone or combined with a second chelator. Blood J Am Society Hematol. 2017;130(17):1923–33. doi:10.1182/blood-2016-10-740241.
   Google Scholar
• Roshni J, Vaishali R, Ganesh KS, Dharani N, Alzahrani KJ, Banjer HJ, Alghamdi AH, Theyab A, Ahmed SS, Patil S. et al. Multi-target potential of Indian phytochemicals against SARS-CoV-2: a docking, molecular dynamics and MM-GBSA approach extended to Omicron B. 1.1. 529. J Infect Public Health. 2022;15(6):662–9. doi:10.1016/j.jiph.2022.05.002.
   PubMed Web of Science ®Google Scholar
• Malik R, Choudhary BS, Srivastava S, Mehta P, Sharma M. Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations. J Biomol Struct Dyn. 2017;35(15):3268–84. doi:10.1080/07391102.2016.1253503.
   PubMed Web of Science ®Google Scholar
• Lozano ML, Segú-Vergés C, Coma M, Álvarez-Roman MT, González-Porras JR, Gutiérrez L, Valcárcel D, Butta N. Elucidating the mechanism of action of the attributed immunomodulatory role of eltrombopag in primary immune thrombocytopenia: an in silico approach. Int J Mol Sci. 2021;22(13):6907. doi:10.3390/ijms22136907.
   PubMed Web of Science ®Google Scholar
• Choudhary S, Kesavan AK, Juneja V, Thakur S. Molecular modeling, simulation and docking of Rv1250 protein from Mycobacterium tuberculosis. Front Bioinform. 2023;3:1125479. doi:10.3389/fbinf.2023.1125479.
   PubMedGoogle Scholar
• Kailass K, Sadovski O, Capello M, Kang Y, Fleming JB, Hanash SM, Beharry AA. Measuring human carboxylesterase 2 activity in pancreatic cancer patient-derived xenografts using a ratiometric fluorescent chemosensor. Chem Sci. 2019;10(36):8428–37. doi:10.1039/C9SC00283A.
   PubMed Web of Science ®Google Scholar
• Li F, Gou X, Xu D, Han D, Hou K, Fang W, Li Y. Improvement of tube formation model of cell: Application for acute hypoxia in in vitro study of angiogenesis. Microvasc Res. 2022;140:104297. doi:10.1016/j.mvr.2021.104297.
   PubMed Web of Science ®Google Scholar
• Kim JS, Lee SD, Lee SJ, Chung MK. Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer. OncoTargets Ther. 2013; 1635–42. doi:10.2147/OTT.S51749.
   PubMed Web of Science ®Google Scholar
• Rao SR, Subbarayan R, Dinesh MG, Arumugam G, Raja STK. Differentiation of human gingival mesenchymal stem cells into neuronal lineages in 3D bioconjugated injectable protein hydrogel construct for the management of neuronal disorder. Exp. Mol. Med. 2016;48(2):209–209. doi:10.1038/emm.2015.113.
   PubMedGoogle Scholar
• Ranga Rao S, Subbarayan R. Passage‐dependent expression of STRO‐1 in human gingival mesenchymal stem cells. J Cell Biochem. 2019;120(3):2810–5. doi:10.1002/jcb.27674.
   PubMed Web of Science ®Google Scholar
• Militi A, Cutroneo G, Favaloro A, Matarese G, Di Mauro D, Lauritano F, Centofanti A, Cervino G, Nicita F, Bramanti A, et al. An immunofluorescence study on VEGF and extracellular matrix proteins in human periodontal ligament during tooth movement. Heliyon. 2019;5(10). doi:10.1016/j.heliyon.2019.e02572.
   PubMed Web of Science ®Google Scholar
• Gęgotek A, Jastrząb A, Dobrzyńska M, Biernacki M, Skrzydlewska E. Exogenous antioxidants impact on uv-induced changes in membrane phospholipids and the effectiveness of the endocannabinoid system in human skin cells. Antioxidants. 2021;10(8):1260. doi:10.3390/antiox10081260.
   Web of Science ®Google Scholar
• Subbarayan R, Murugan Girija D, Raja STK, Krishnamoorthy A, Srinivasan D, Shrestha R, Srivastava N, Ranga Rao S. Conditioned medium-enriched umbilical cord mesenchymal stem cells: a potential therapeutic strategy for spinal cord injury, unveiling transcriptomic and secretomic insights. Mol Biol Rep. 2024;51(1):570. doi:10.1007/s11033-024-09503-8.
   PubMed Web of Science ®Google Scholar
• Provan D, Saleh M, Goodison S, Rafi R, Stone N, Hamilton JM, Hassani H, Mayer B, Uhl J, Jenkins J, et al. The safety profile of Eltrombopag, a novel oral platelet growth factor, in thrombocytopenic patients and healthy subjects. J Clin Oncol. 2006;24(18_suppl):18596–18596. doi:10.1200/jco.2006.24.18_suppl.18596.
   Web of Science ®Google Scholar
• Kumar VP, Holmes-Hampton GP, Biswas S, Stone S, Sharma NK, Hritzo B, Guilfoyle M, Eichenbaum G, Guha C, Ghosh SP. Mitigation of total body irradiation-induced mortality and hematopoietic injury of mice by a thrombopoietin mimetic (JNJ-26366821). Sci Rep. 2022;12(1):3485. doi:10.1038/s41598-022-07426-7.
   PubMed Web of Science ®Google Scholar
• Noetzli LJ, French SL, Machlus KR. New insights into the differentiation of megakaryocytes from hematopoietic progenitors. Arterioscler Thromb Vasc Biol. 2019;39(7):1288–300. doi:10.1161/ATVBAHA.119.312129.
   PubMed Web of Science ®Google Scholar
• Hollingsworth SA, Dror RO. Molecular dynamics simulation for all. Neuron. 2018;99(6):1129–43. doi:10.1016/j.neuron.2018.08.011.
   PubMed Web of Science ®Google Scholar
• Kapla J, Rodríguez-Espigares I, Ballante F, Selent J, Carlsson J. Can molecular dynamics simulations improve the structural accuracy and virtual screening performance of GPCR models? PLOS Comput Biol. 2021;17(5):e1008936. doi:10.1371/journal.pcbi.1008936.
   PubMed Web of Science ®Google Scholar
• Kufareva I, Abagyan R. Methods of protein structure comparison. Homol Model: Methods Mol Biol. 2012;857:231–57. doi:10.1007/978-1-61779-588-6_10.
   PubMedGoogle Scholar
• Bhowmick S, AlFaris NA, ALTamimi JZ, ALOthman ZA, Aldayel TS, Wabaidur SM, Islam MA. Screening and analysis of bioactive food compounds for modulating the CDK2 protein for cell cycle arrest: multi-cheminformatics approaches for anticancer therapeutics. J Mol Struct. 2020;1216:128316. doi:10.1016/j.molstruc.2020.128316.
   Web of Science ®Google Scholar
• Muralidharan N, Sakthivel R, Velmurugan D, Gromiha MM. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. J Biomol Struct Dyn. 2021;39(7):2673–8. doi:10.1080/07391102.2020.1752802.
   PubMed Web of Science ®Google Scholar
• Cheng G. Eltrombopag, a thrombopoietin-receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile. Ther Adv Hematol. 2012;3(3):155–64. doi:10.1177/2040620712442525.
   PubMedGoogle Scholar
• de Graaf CA, Metcalf D. Thrombopoietin and hematopoietic stem cells. Cell Cycle. 2011;10(10):1582–9. doi:10.4161/cc.10.10.15619.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou J, Xu X, Du F, Nie M, Hu L, Ma Y, Liu M, Yu S, Zhang J. et al. Matrigel/umbilical cord-derived mesenchymal stem cells promote granulosa cell proliferation and ovarian vascularization in a mouse model of premature ovarian failure. Stem Cells Dev. 2021;30(15):782–96. doi:10.1089/scd.2021.0005.
   PubMed Web of Science ®Google Scholar
• Davulcu EA, Soyer NA, Vural F. Eltrombopag for the treatment of allogeneic hematopoietic stem cell transplantation-related poor graft function. Cureus. 2023;15(9):e44555. doi:10.7759/cureus.44555.
   PubMed Web of Science ®Google Scholar
• Muntión S, Preciado S, Sánchez-Luis E, Corchete L, Díez-Campelo M, Osugui L, Martí-Chillón G-J, Vidriales M-B, Navarro-Bailón A, De Las Rivas J, et al. Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells. Ther Adv Hematol. 2022;13:20406207221142137. doi:10.1177/20406207221142137.
   Web of Science ®Google Scholar
• Chatterjee S, Maity A, Chowdhury S, Islam MA, Muttinini RK, Sen D. In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme. J Biomol Struct Dyn. 2021;39(14):5290–303. doi:10.1080/07391102.2020.1787228.
   PubMed Web of Science ®Google Scholar
• Coppes RP, van der Goot A, Lombaert IM. Stem cell therapy to reduce radiation-induced normal tissue damage. Semin Radiat Oncol. 2009;19(2):112–21. doi:10.1016/j.semradonc.2008.11.005.
   Google Scholar